Evogene (EVGN) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Evogene Ltd. reported a 35% increase in total revenues for the first nine months of 2024, driven by Casterra’s seed sales, despite a drop in Q3 revenue compared to last year. The company has strengthened its cash position by reducing expenses and completed a $5.5 million fundraising. Evogene is enhancing its AI tech-engines through collaboration with Google Cloud to expand its market potential in life-science product development.
For further insights into EVGN stock, check out TipRanks’ Stock Analysis page.
